z-logo
open-access-imgOpen Access
Effects of intake of breakfast or caffeine‐containing beverages on measurement of circulating chromogranin A in plasma
Author(s) -
Robbins Helen L.,
Symington Megan,
Mosterman Barbara,
Tranter Fiona,
Davies Louise,
Randeva Harpal S.,
Penedo Ana,
Ferreira Clara,
Darby Catherine,
Grammatopoulos Dimitri,
Kaltsas Gregory,
Weickert Martin O.
Publication year - 2019
Publication title -
gastrohep
Language(s) - English
Resource type - Journals
ISSN - 1478-1239
DOI - 10.1002/ygh2.208
Subject(s) - postprandial , medicine , context (archaeology) , chromogranin a , cohort , crossover study , gastroenterology , endocrinology , placebo , insulin , immunohistochemistry , paleontology , alternative medicine , pathology , biology
Summary Context Sampling in the nonfasted state might result in false‐high measurements of plasma chromogranin A (CgA), a key biomarker for patients with gastro‐entero‐pancreatic neuroendocrine neoplasms (GEP‐NENs). Objective To investigate whether intake of a 5‐item English breakfast together with tea/coffee (Bfast‐T/C) or intake of tea/coffee (T/C) alone relevantly influences postprandial CgA in GEP‐NENs and controls. Methods In a randomised, controlled, double crossover study, we investigated in >10‐hour overnight fasted individuals the effects of Bfast‐T/C vs T/C vs the ongoing fasted state on 180‐minute postprandial plasma CgA concentrations (28 patients with GEP‐NENs, of those 22 on treatment with long‐acting somatostatin analogues (SSA); and 11 controls). Ten participants (8 GEP‐NEN, 2 controls) were on treatment with proton pump inhibitors (PPI). Results Intake of Bfast‐TC but not T/C alone increased CgA in the pooled cohort, reflecting the situation in screening, from 90 minute [area under the curve (AUC) CgA0 ‐ 180 minute, ongoing fasted 172.6 ± 4.6 vs T/C 173.3 ± 5.2 vs Bfast‐TC 204.2 ± 7.9, P  = 0.0002]. Postprandial responses to Bfast‐T/C in controls and GEP‐NENs were comparable. PPI usage was associated with markedly increased fasted CgA in the pooled cohort (429.3 ± 90.4 vs 91.0 ± 14.7 µg/L; P  < 0.0001). AUC CgA 0 ‐ 180 minute remained higher following Bfast‐T/C after exclusion of PPI users ( P  < 0.05). In GEP‐NENs, effects of Bfast‐T/C on postprandial CgA raises were more pronounced in patients not treated with SSA. Conclusions Intake of Bfast‐T/C, but not T/C alone, increased postprandial CgA in both patients with GEP‐NENs and controls up to 34%. Fasted CgA measurements should be sought, if possible, and PPIs paused prior to measurement. ClinicalTrials.gov Identifier: NCT03288402.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom